Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone — Stella

Recruiting

Back to Glaucoma, Open-angle trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Glaukos Investigator Site, Kenosha, Wisconsin

Key details

Phase

Post-approval study

Sponsor

Glaukos Corporation

Enrollment target

~132 participants

Started

January 2025

Primary completion

August 2026

Age range

45 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov